Millions of Eye Drop Units Recalled From Major Retailers Following Federal Sterility Compliance Concerns

More than 3.1 million eye drop bottles from Walgreens, CVS, and Kroger have been recalled. K.C. Pharmaceuticals cites sterility concerns in a Class II FDA alert.

By: AXL Media

Published: Apr 4, 2026, 5:47 AM EDT

Source: Information for this report was sourced from CBS News

Millions of Eye Drop Units Recalled From Major Retailers Following Federal Sterility Compliance Concerns - article image
Millions of Eye Drop Units Recalled From Major Retailers Following Federal Sterility Compliance Concerns - article image

Massive Recall Targets Critical Ophthalmic Supplies

A significant disruption in the over-the-counter pharmaceutical market has emerged following a sweeping recall of millions of lubricant and redness-relief eye drops. According to a notice from the Food and Drug Administration (FDA), the manufacturer K.C. Pharmaceuticals has pulled over 3.1 million units from shelves amid growing concerns regarding the sterile environment of the production process. While the agency has classified the event as a Class II recall, indicating that the probability of serious adverse health consequences is considered remote, the scale of the distribution has prompted an immediate response from major national pharmacy chains and grocery retailers.

Retail Giants Scramble to Remove Contaminated Lots

The logistical impact of the recall spans the breadth of the American retail landscape, affecting heavyweights such as Walgreens, CVS, and Rite Aid. According to the March 3 alert, the largest single affected lot involves more than one million bottles of Dry Eye Relief Eye Drops, which were also distributed through regional grocers like H-E-B and Harris Teeter. Retailers are currently tasked with identifying and isolating these specific lots to prevent further consumer purchases, as the products were available under various private labels and store brands that many shoppers may not immediately associate with a single manufacturer.

Specific Formulas Identified in Federal Alert

The scope of the recall involves eight specific formulations designed for a variety of ocular conditions, ranging from simple lubrication to advanced redness relief. Key products include Artificial Tears Sterile Lubricant, Sterile Eye Drops Original Formula, and Eye Drops Advanced Relief, many of which utilize active ingredients like glycerin, povidone, and tetrahydrozoline. According to Aimee Picchi, the FDA’s classification of these items highlights a potential for temporary or medically reversible health issues, marking a significant intervention in the consumer health sector to maintain the integrity of ophthalmic medical standards.

Categories

Topics

Related Coverage